Minimally Invasive Surgical Instrument Market - Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices), Surgery Type (Cardiothoracic, Gastrointestinal, Orthopedic, Gynecological), End-use & Forecast, 2024-2032

Description

List of Tables

Minimally Invasive Surgical Instrument Market is anticipated to witness more than 8.1% CAGR between 2024 and 2032 owing to the technological advancements in medical sector. The increasing prevalence of chronic diseases and a growing aging population worldwide are propelling the need for less invasive, quicker, and safer surgical interventions.

As per the UN World Population Prospects, in 2022, there were nearly 771 million people aged 65 years or older which was almost 10% of the total global population. By 2050, the geriatric proportion is expected to increase, reaching 16% of the total population. The elderly are more susceptible to various chronic and lifestyle ailments. They opt for minimally invasive procedures with quick recovery time, bolstering the demand for related surgical instruments.

The minimally invasive surgical instruments market is classified based on product, surgery type, end-use, and region.

The orthopedic surgery segment is expected to record strong demand for these instruments through 2032 as they are transforming the landscape of joint replacements, arthroscopy, and spine surgeries. The demand for quicker recovery times, reduced postoperative pain, and smaller incisions has fueled the adoption of these instruments in orthopedic surgeries. Surgeons and patients are benefiting from enhanced precision and minimal tissue disruption, marking a paradigm shift in the way orthopedic procedures are performed.

The ambulatory surgical centers (ASCs) segment is anticipated to witness substantial growth through 2032. The efficiency and cost-effectiveness offered by ASCs make them an attractive option for both patients and healthcare providers. Minimally invasive procedures align perfectly with the goals of ASCs, providing the opportunity for quicker turnaround times, increased patient throughput, and reduced overall healthcare costs. The ASCs strive to ensure minimally invasive procedures are more accessible to a broader patient base.

Europe minimally invasive surgical instruments industry size will expand significantly over 2023-2032, due to robust healthcare infrastructure and a proactive approach towards technological integration. The growing acceptance of advanced technologies, coupled with the rising demand for outpatient procedures, fuel the product demand. The supportive regulatory frameworks in Europe will create massive growth opportunities for leading players in the region.

Product Code: 7717

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global minimally invasive surgical instrument market 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Surgery type trends
- 2.1.5 End-use trends

Chapter 3 Minimally Invasive Surgical Instrument Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of chronic diseases
  - 3.2.1.2 Advancements in technology
  - 3.2.1.3 Growing aging population
  - 3.2.1.4 Surging demand for minimally invasive procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of surgical instruments
  - 3.2.2.2 Limited access to trained professionals
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By surgery type
- 3.3.3 By end-use
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technological landscape
3.7 Pricing analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Company market share analysis, 2023
4.4 Competitive analysis of major market players, 2023
4.5 Competitive positioning matrix, 2023
4.6 Strategy dashboard, 2023

Chapter 5 Minimally Invasive Surgical Instrument Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Handheld instruments
- 5.2.1 Graspers
- 5.2.2 Retractors/elevators
- 5.2.3 Suturing instruments
- 5.2.4 Dilators
- 5.2.5 Other handheld instruments
5.3 Inflation devices
5.4 Cutter instruments
5.5 Guiding devices
5.6 Electrosurgical devices
5.7 Auxiliary devices
5.8 Monitoring & visualization devices

Chapter 6 Minimally Invasive Surgical Instrument Market Size and Forecast, By Surgery Type, 2018-2032 (USD Million)

6.1 Key trends, by surgery type
6.2 Cardiothoracic surgery
6.3 Gastrointestinal surgery
6.4 Orthopedic surgery
6.5 Gynecological surgery
6.6 Cosmetic & bariatric surgery
6.7 Urological surgery
6.8 Other surgery types

Chapter 7 Minimally Invasive Surgical Instrument Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals & clinics
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Minimally Invasive Surgical Instrument Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Medtronic Plc
9.2 Siemens Healthineer AG
9.3 Ethicon, Inc. (Johnson & Johnson)
9.4 GE Healthcare
9.5 Abbott Laboratories
9.6 Intutive Surgical, Inc.
9.7 Nuvasive, Inc.
9.8 Zimmer Biomet
9.9 Stryker Corporation
9.10 Boston Scientific Corporation
9.11 B. Braun Melsungen AG
9.12 CONMED Corporation
9.13 Smith & Nephew Plc.
9.14 Becton, Dickinson and Company